Assessment of left ventricular mass changes after arteriovenous fistula surgical banding in end-stage renal disease

Camilo Cortesi, Juan C. Duque, Sedki Mai, Laisel Martinez, Adriana Dejman, Roberto I Vazquez-Padron, Loay Salman, Marwan Tabbara

Research output: Contribution to journalArticlepeer-review

Abstract

Left ventricular hypertrophy (LVH) is a multifactorial complication frequently seen in patients with advanced chronic kidney disease. An arteriovenous fistula (AVF) is the preferred method for hemodialysis access. Once functional, AVFs demonstrate better patency rates and fewer complications when compared to other forms of vascular access. AVFs have been implicated in cardiac remodeling, but it is controversial whether those changes can be reversed by surgical ligation or blood flow reduction. In this study, we describe a cohort of asymptomatic patients with LVH who underwent AVF banding with a two-dimensional-echocardiogram done before and after the intervention to evaluate the association between AVF surgical banding and left ventricular mass (LVM) changes. Our results show that AVF surgical banding did not alter the left ventricular mass index (LVMI) with a mean prebanding LVMI of 70.3 ± 57.5 g/m2 and mean postbanding LVMI of 81.9 ± 55.9 g/m2, (P = 0.4). Our study shows that AVF flow reduction by surgical banding did not alter LVMI, and therefore LVH, in end-stage renal disease patients who have not yet shown clinical manifestations of cardiac disease.

Original languageEnglish (US)
Pages (from-to)1280-1289
Number of pages10
JournalSaudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia
Volume29
Issue number6
DOIs
StatePublished - Nov 1 2018

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Assessment of left ventricular mass changes after arteriovenous fistula surgical banding in end-stage renal disease'. Together they form a unique fingerprint.

Cite this